AI is finding its way into every corner of biotech and pharmaceutical research, but like other industries, it’s never quite as straightforward to implement as one would like. Converge Bio has built a tool for companies to make their biology-focused LLMs actually work, from “enriching” their data to explaining their answers. The company has raised $5.5 million in a seed round to scale its product.
Source link
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on for any glitch kindly connect at office@startupnews.fyi